Thermo Fisher will display its newest innovations in booth 708 at the 66th Annual American Society for Mass Spectrometry (ASMS) Conference, being held June 3-7 at the San Diego Convention Center.

New software offers improved workflow efficiency with enhanced data management and the tools to support 21 CFR Part 11 compliance across the SCIEX mass spectrometry portfolio.

Improving the accuracy and user-friendliness of mass spec technologies to enable critical decisions in safety, healthcare and nutrition.

At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets.

The co-marketing agreement combines Shimadzu’s latest Q-TOF technology with Protein Metrics’ software, which automates biotherapeutic characterization workflows.

The Shimadzu LCMS-9030 is a research grade mass spectrometer designed to deliver high-resolution, accurate-mass detection with incredibly fast data acquisition rates, allowing scientists to identify and quantify more compounds with greater confidence.

Lonza Pharma & Biotech to manufacture clinical batches of TxCell’s HLA-A2 CAR-Treg cellular product from its production site in Geleen (NL).

Industry-leading adapters mitigate index hopping and spread of signal in
next gen sequencing applications.

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

Lonza has announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.